SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-092338
Filing Date
2023-08-16
Accepted
2023-08-16 11:20:22
Documents
12
Period of Report
2023-08-14
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2323885d1_8k.htm   iXBRL 8-K 44136
  Complete submission text file 0001104659-23-092338.txt   219349

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acur-20230814.xsd EX-101.SCH 3289
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20230814_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20230814_pre.xml EX-101.PRE 22363
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2323885d1_8k_htm.xml XML 3224
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10113 | Film No.: 231177017
SIC: 2834 Pharmaceutical Preparations